Show simple item record

dc.contributor.authorMyburgh, Jeanri
dc.contributor.authorDube, Admire
dc.contributor.authorLiebenberg, Wilna
dc.date.accessioned2024-07-31T10:38:07Z
dc.date.available2024-07-31T10:38:07Z
dc.date.issued2023
dc.identifier.citationMyburgh, J., Liebenberg, W., Willers, C., Dube, A. and Gerber, M., 2023. Investigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems. Pharmaceutics, 15(10), p.2413.en_US
dc.identifier.issn19994923
dc.identifier.urihttp://dx.doi.org/10.3390/pharmaceutics15102413
dc.identifier.urihttp://hdl.handle.net/10566/9384
dc.description.abstractThe aim was to assess the suitability of three nano-based transdermal drug delivery systems containing ibuprofen: a nano-emulsion, a nano-emulgel, and a colloidal suspension with ibuprofen-loaded nanoparticles. Understanding the transdermal delivery of ibuprofen using nanobased drug delivery systems can lead to more effective pain relief and improved patient compliance. Characterization tests assessed the suitability of the developed drug delivery systems. Membrane release and skin diffusion studies, along with tape stripping, were performed to determine drug release and skin permeation of ibuprofen. In vitro cytotoxicity studies on HaCaT cells were conducted using MTT and neutral red assays to evaluate the safety of the developed drug delivery systems. Characterization studies confirmed stable drug delivery systems with ideal properties for transdermal delivery.en_US
dc.language.isoenen_US
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)en_US
dc.subjectIbuprofenen_US
dc.subjectNSAIDsen_US
dc.subjectNano-emulsionen_US
dc.subjectColloidal suspensionen_US
dc.subjectIn vitro cytotoxicityen_US
dc.titleInvestigation and evaluation of the transdermal delivery of Ibuprofen in various characterized nano-drug delivery systemsen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record